Laura Q M Chow (Laura Q Chow)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Targeted oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Tae Won Kim, Howard A Burris, Maria J de Miguel Luken, Michael J Pishvaian, Yung-Jue Bang, Michael S Gordon, Ahmad Awada, D Ross Camidge, F Stephen Hodi, Grant A McArthur, Wilson H Miller, Andres Cervantes, Laura Q M Chow, Alexander M Lesokhin, Annemie Rutten, Mario Sznol, Deepali Rishipathak, Shang-Chiung Chen, Eric G Stefanich, Tony Pourmohamad, Maria Anderson, Jeong Kim, Mahrukh Huseni, Ina Rhee, Lillian L Siu
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)
Laura C Kennedy, Jun Lu, Sydney Kuehn, Arturo B Ramirez, Edward Lo, Yao Sun, Lance U'Ren, Laura Q M Chow, Zhengjia Chen, Petros D Grivas, Eric P Kaldjian, Vijayakrishna K Gadi
Liquid Biopsy Assessment of Circulating Tumor Cell PD-L1 and IRF-1 Expression in Patients with Advanced Solid Tumors Receiving Immune Checkpoint Inhibitor. Targeted oncology 17 (3) (2022)
Laura Q M Chow, Fabrice Barlesi, Erin M Bertino, Martin J Van Den Bent, Heather A Wakelee, Patrick Y Wen, Chao-Hua Chiu, Sergey Orlov, Rita Chiari, Margarita Majem Tarruella, Mark McKeage, Chong-Jen Yu, Pilar Garrido Lopez, Felipe K Hurtado, Pilar Cazorla Arratia, Yuanbo Song, Fabrice Branle, Michael Shi, Dong Wan Kim
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Hossein Borghaei, Scott N Gettinger, Everett E Vokes, Laura Q M Chow, Marco Angelo Burgio, Javier De Castro Carpeño, Adam Pluzanski, Arrieta Oscar, Osvaldo Arén Frontera, Rita Chiari, Charles Butts, Joanna Wójcik-Tomaszewska, Bruno Coudert, Marina Chiara Garassino, Neal Ready, Enriqueta Felip Font, Miriam Alonso García, David Michael Waterhouse, Manuel Dómine, Fabrice Barlesi, Scott Antonia, Markus Wohlleber, David E Gerber, Grzegorz Czyzewicz, David R Spigel, Lucio Crino, Wilfried Enst Erich Eberhardt, Ang Li, Sathiya Marimuthu, Julie Brahmer
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2021)
Edward B Garon, Alexander I Spira, Melissa Johnson, Lyudmila Bazhenova, Joseph Leach, Amy L Cummings, Albert Candia, Robert L Coffman, Mary J Janatpour, Robert Janssen, Erick Gamelin, Laura Q M Chow
A Phase Ib Open-Label, Multicenter Study of Inhaled DV281, a TLR9 Agonist, in Combination with Nivolumab in Patients with Advanced or Metastatic Non-small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (16) (2021)